# Simultaneous Boost in Neoadjuvant Radiotherapy for Rectal Cancer

> **NCT07200141** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 156 (estimated)

## Conditions studied

- Locally Advanced Rectal Adenocarcinoma

## Interventions

- **RADIATION:** GTV 58.75 Gy/25 fractions(Simultaneous Integrated Boost)
- **RADIATION:** GTV 50 Gy/25 fractions(Simultaneous Integrated Boost)
- **DRUG:** Concurrent Chemotherapy
- **PROCEDURE:** Total mesorectal excision (TME) surgery or non-operative management

## Key facts

- **NCT ID:** NCT07200141
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2028-12-01
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2025-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07200141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07200141, "Simultaneous Boost in Neoadjuvant Radiotherapy for Rectal Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07200141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*